February 24, 2016
US veterinarians' meeting to discuss effects of Diamond V's SynGenX®
Antibiotic stewardship will be the key focus of the upcoming annual meeting of the American Association of Swine Veterinarians (AASV) on February 27 - March 1 in New Orleans, Louisiana, US.
New research scheduled for presentation to AASV in New Orleans includes "Quantitative assessment of prevalence and severity to understand impact of Lactobacillus acidophilus fermentation product (SynGenX®) in a herd with endemic (E. coli) K88 and Salmonella post-wean" by independent researcher Sarah Probst Miller. She is accompanied by co-authors including Alex Ramirez (Iowa State University), Benjamin Bass (Diamond V), and Jason Frank.
"Previous controlled studies have shown that (Diamond V's) SynGenX supports feed intake, weight gain, and gut health and wellness in young pigs," Dr. Bass said. "The product has also been shown to affect enteric bacteria concentrations and the immune response. The purpose of Dr. Miller's research was to evaluate how these effects may assist pigs in coping with both E. coli and Salmonella before they cause disease."
SynGenX is a natural nutritional health product used in swine diets. The DV Bioactives™ in SynGenX not only improve butyrate production, but also support a healthy bacterial balance to optimise immune function and overall health of weaned pigs.
"SynGenX provides research-proven support for immunity, health, and performance in young pigs," Dan Mueller, Diamond V's Swine Business Development Manager, said.
Veterinarians are leading the effort to optimise antibiotic use and preserve the efficacy of current therapeutic treatments. Interest is high in researching and evaluating natural alternatives to promote pig health.
In young pigs, pathogenic strains of E. coli and Salmonella are a particular challenge.